In this series of BCL clinical specimens, we observed a correlation of tumor Gal-9 abundance with tumor stage and level of EBNA1 expression, but no influence of Gal-9 abundance on disease outcome (data not shown) in this small patient series. Here, LGALS9 is linked to neoplasm.